People_

Professor Edmund Lau

Clinical Professor
Sydney Medical School
Central Clinical School
Faculty of Medicine and Health

Phone

9515 8195

Fax

9515 8196

Email

edmund.lau@sydney.edu.au

Biographical details

Prof Edmund Lau is a respiratory and sleep physician and currently holds appointment as Senior Staff Specialist at the Royal Prince Alfred Hospital. He has a PhD in pulmonary vascular medicine from University of Sydney. He worked at the French National Referral Centre for Severe Pulmonary Hypertension as a post-doctoral fellow prior to returning to Australia.He has participated as member of international task force on the pulmonary circulation. He is currently the medical director of the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ) Registry.

Research interests

Main research theme focuses on a devastating disease known as pulmonary arterial hypertension (PAH), which causes blockage of the small blood vessels of the lungs. Areas of research in PAH encompass:

Epidemiological studies with the Australian and New Zealand Pulmonary Hypertension Registry.
Functional imaging of the right ventricle-pulmonary circulation.
Exercise physiology of the pulmonary circulation.
Novel therapies for PAH.

Current projects

Honors and PhD projects opportunities are available

Themes

Obesity, Diabetes and Cardiovascular Disease

Keywords

Physiology, Respiratory tract diseases

International links

France

(Professor Denis Chemla, University of Paris-Sud) Haemodynamics of pulmonary circulation; exercise response in pulmonary vascular disease

France

(Professor Marc Humbert, INSERM UMR_S999) Translational and clinical research in pulmonary arterial hypertension

Publications

By Type

Expand all

Journals

Lau, E., Bloomfield, P., Kotlyar, E., Makanji, Y., Yu, D., Tan, J., Casorso, J., Kouhkamari, M., Lim, S., Wu, D. (2024). Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study. Journal of Medical Economics, 27(1), 596-604. [More Information]
Kearney, K., Keogh, A., Kotlyar, E., Lavender, M., McWilliams, T., Williams, T., Whitford, H., Weintraub, R., Wrobel, J., Ellender, C., Lau, E., Celermajer, D., Cordina, R., et al (2024). Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy. Chest. [More Information]
Hungerford, S., Kearney, K., Li, C., Song, N., Everett, K., Gulati, G., Olsen, N., Lau, E., Jabbour, A., Bart, N., et al (2024). Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension. Journal of the American Heart Association, 13(23). [More Information]
Chao, H., Yee, B., Hsu, C., Chen, H., Lau, E. (2024). Sleep-related disorders in patients with precapillary pulmonary hypertension. Sleep Medicine Reviews, 77, 101972. [More Information]
Karimi Galougahi, K., Zhang, Y., Kienzle, V., Liu, C., Quek, L., Patel, S., Lau, E., Cordina, R., Figtree, G., Celermajer, D. (2023). β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension. Physiological Reports, 11(1). [More Information]
Chandrasekara, S., Lau, E., Anderson, J., Collins, N., Cordina, R., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., Keogh, A., et al (2023). Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing. Heart, Lung, and Circulation, 32(2), 156-165. [More Information]
Hungerford, S., Kearney, K., Song, N., Kotlyar, E., Bart, N., Lau, E., Jabbour, A., Hayward, C., Muller, D., Adji, A. (2023). Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification. Physiological Reports, 11(7). [More Information]
Bell, J., Munoz, P., Raffan, F., Shah, K., Shaw, M., Taylor, N., Visser, S., Yozghatlian, V., Wong, K., Sivam, S., Dwyer, T., Cunich, M., Dentice, R., Jo, H., Lau, E., et al (2023). Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Internal Medicine Journal. [More Information]
Hungerford, S., Kearney, K., Song, N., Bart, N., Kotlyar, E., Lau, E., Jabbour, A., Hayward, C., Muller, D., Adji, A. (2023). Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension. ESC Heart Failure, 10(3), 1811-1821. [More Information]
Morland, K., Williams, P., Harikrishnan, S., Minty, E., Hobohm, L., Jose, A., Badagliacca, R., Lau, E., Jing, Z., Vanderpool, R., et al (2023). Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulmonary Circulation, 13(4), e12317. [More Information]
Othman, F., Bailey, B., Collins, N., Lau, E., Tanous, D., Rao, K., Celermajer, D., Cordina, R. (2022). Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease. Journal of the American Heart Association, 11(15). [More Information]
Anderson, J., Lau, E. (2022). Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia. JACC: Asia, 2(5), 538-546. [More Information]
Bell, J., Sivam, S., Dentice, R., Dwyer, T., Jo, H., Lau, E., Munoz, P., Nolan, S., Taylor, N., Visser, S., Yozghatlian, V., Wong, K. (2022). Quality of home spirometry performance amongst adults with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 84-87. [More Information]
Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Adelstein, S., Webster, S., Corte, T. (2021). Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration, 100(9), 853-864. [More Information]
Kearney, K., Gold, J., Corrigan, C., Dhital, K., Boshell, D., Haydock, D., McGiffin, D., Wilson, M., Collins, N., Cordina, R., Lau, E., et al (2021). Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry. Respirology, 26(12), 1171-1180. [More Information]
Cooper, W., Mahar, A., Myers, J., Grainge, C., Corte, T., Williamson, J., Vallely, M., Lai, S., Mulyadi, E., Torzillo, P., Lau, E., Troy, L., et al (2021). Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features: Further Lessons from COLDICE, a Prospective Multi-Center Study. American Journal of Respiratory and Critical Care Medicine, 203(10), 1306-1313. [More Information]
Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Webster, S., Adelstein, S., Corte, T. (2021). Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine, 187, 106581. [More Information]
Tran, D., Munoz, P., Lau, E., Alison, J., Brown, M., Zheng, Y., Corkery, P., Wong, K., Lindstrom, S., Celermajer, D., Davis, G., Cordina, R. (2021). Inspiratory Muscle Training Improves Inspiratory Muscle Strength and Functional Exercise Capacity in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Pilot Randomised Controlled Study. Heart, Lung, and Circulation, 30(3), 388-395. [More Information]
Cooper, W., Mahar, A., Myers, J., Grainge, C., Corte, T., Williamson, J., Lau, E., Raghu, G., Troy, L. (2021). Letters to the Editor. Archives of Pathology & Laboratory Medicine, 145(11), 1326-1327. [More Information]
McLean, A., Webster, S., Fry, M., Lau, E., Corte, P., Torzillo, P., Troy, L., Jo, H., Geis, M., Rhodes, J., Spencer, L., Corte, T., et al (2021). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology, 26(1), 80-86. [More Information]
Kearney, K., Kotlyar, E., Lau, E. (2021). Pulmonary Vascular Disease as a Systemic and Multisystem Disease. Clinics in Chest Medicine, 42(1), 167-177. [More Information]
Humbert, M., Lau, E. (2021). Risk Stratification in PAH: Do Not Forget the Patient Perspective!. American Journal of Respiratory and Critical Care Medicine, 203(6), 675-677. [More Information]
Montani, D., Girerd, B., Jaïs, X., Laveneziana, P., Lau, E., Bouchachi, A., Hascoët, S., Günther, S., Godinas, L., Parent, F., et al (2021). Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation. European Respiratory Journal, 58(1), 2004229-1-2004229-16. [More Information]
Chemla, D., Berthelot, E., Weatherald, J., Lau, E., Savale, L., Beurnier, A., Montani, D., Sitbon, O., Attal, P., Boulate, D., et al (2021). The isobaric pulmonary arterial compliance in pulmonary hypertension. ERJ Open Research, 7(2), 941-2020. [More Information]
Kearney, K., Lau, E., Darley, D., Romfh, A., Bart, N., Kotlyar, E., Hayes, D., Khush, K., Keogh, A. (2021). Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies. Journal Of Heart And Lung Transplantation, 40(8), 841-849. [More Information]
Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Myers, J., Lai, S., Mulyadi, E., Torzillo, P., Jo, H., Harris, B., Lau, E., et al (2020). Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. The Lancet Respiratory Medicine, 8(2), 171-181. [More Information]
Khou, V., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Lau, E., et al (2020). Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology, 25(8), 863-871. [More Information]
Lau, E., Grainge, C., Williamson, J., Corte, T., Cooper, W., Phillips, M., Torzillo, P., Vallely, M., Raghu, G., Troy, L. (2020). Methodologies of COLDICE and Cryo-PID studies: details make the difference. Annals of Translational Medicine, 8(12), 781. [More Information]
Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Keogh, A., et al (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart, Lung, and Circulation, 29(10), 1459-1468. [More Information]
Piper, A., Lau, E. (2020). Positive airway pressure in obesity hypoventilation: Getting to the heart of the matter. American Journal of Respiratory and Critical Care Medicine, 201(5), 509-511. [More Information]
Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., Lau, E., et al (2020). Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. European Respiratory Journal, 56(1), 1901654. [More Information]
Anderson, J., Lau, E., Lavender, M., Benza, R., Celermajer, D., Collins, N., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., et al (2020). Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Chest, 157(1), 162-172. [More Information]
Nanayakkara, B., Lau, E., Yee, B., Gauthier, G., Melehan, K., Celermajer, D., Cordina, R. (2020). Sleep disordered breathing in adults living with a Fontan circulation and CPAP titration protocol. International Journal of Cardiology, 317, 70-74. [More Information]
Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Lai, S., Mulyadi, E., Torzillo, P., Lau, E., et al (2019). Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study. BMJ Open Respiratory Research, 6(1), 1-8. [More Information]
Chemla, D., Boulate, D., Weatherald, J., Lau, E., Attal, P., Savale, L., Montani, D., Fadel, E., Mercier, O., Sitbon, O., et al (2019). Golden ratio and the proportionality between pulmonary pressure components in pulmonary arterial hypertension. Chest, 155(5), 991-998. [More Information]
Troy, L., Young, I., Lau, E., Wong, K., Yee, B., Torzillo, P., Corte, T. (2019). Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease. Respirology, 24(10), 996-1004. [More Information]
Humbert, M., Lau, E. (2019). POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes. Chest, 156(6), 1039-1042. [More Information]
Humbert, M., Lau, E. (2019). Rebuttal From Drs Humbert and Lau. Chest, 156(6), 1045-1046. [More Information]
Chemla, D., Boulate, D., Weatherald, J., Lau, E., Herve, P. (2019). Response. Chest, 156(3), 630-631. [More Information]
Gunther, S., Perros, F., Rautou, P., Girerd, B., Ghigna, M., Cazals-Hatem, D., Lau, E., Dorfmuller, P., Sitbon, O., Valla, D., et al (2019). Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease. American Journal of Pathology, 189(6), 1159-1175. [More Information]
Bailey, D., Farrow, C., Lau, E. (2019). V/Q SPECT - Normal Values for Lobar Function and Comparison With CT Volumes. Seminars in Nuclear Medicine, 49(1), 58-61. [More Information]
Rutting, S., Xenaki, D., Lau, E., Horvat, J., Wood, L., Hansbro, P., Oliver, B. (2018). Dietary omega-6, but not omega-3 polyunsaturated or saturated fatty acids, increase inflammation in primary lung mesenchymal cells. AJP: Lung Cellular and Molecular Physiology, 314(6), L922-L935. [More Information]
Phan, K., Jo, H., Xu, J., Lau, E. (2018). Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis. Heart, Lung, and Circulation, 27(1), 89-98. [More Information]
Tran, D., Lau, E., Celermajer, D., Davis, G., Cordina, R. (2018). Pathophysiology of exercise intolerance in pulmonary arterial hypertension. Respirology, 23(2), 148-159. [More Information]
Dumas, O., Despreaux, T., Perros, F., Lau, E., Andujar, P., Humbert, M., Montani, D., Descatha, A. (2018). Respiratory effects of trichloroethylene. Respiratory Medicine, 134, 47-53. [More Information]
Strange, G., Lau, E., Giannoulatou, E., Corrigan, C., Kotlyar, E., Kermeen, F., Williams, T., Celermajer, D., Dwyer, N., Whitford, H., et al (2018). Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Heart, Lung, and Circulation, 27(11), 1368-1375. [More Information]
Kovacs, G., Herve, P., Barbera, J., Chaouat, A., Chemla, D., Condliffe, R., Garcia, G., Grunig, E., Howard, L., Humbert, M., et al (2017). An official European Respiratory Society statement: pulmonary haemodynamics during exercise. European Respiratory Journal, 50(5), 1-18. [More Information]
Weatherald, J., Boucly, A., Lau, E., Godinas, L., Savale, L., Jais, X., Montani, D., Sitbon, O., Simonneau, G., Humbert, M., et al (2017). Are indexed values better for defining exercise pulmonary hypertension? European Respiratory Journal, 50(3), 1-4. [More Information]
Montani, D., Girerd, B., Jais, X., Levy, M., Amar, D., Savale, L., Dorfmuller, P., Seferian, A., Lau, E., Eyries, M., et al (2017). Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study. The Lancet Respiratory Medicine, 5(2), 125-134. [More Information]
Godinas, L., Sattler, C., Lau, E., Jais, X., Taniguchi, Y., Jevnikar, M., Weatherald, J., Sitbon, O., Savale, L., Montani, D., et al (2017). Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension. Journal Of Heart And Lung Transplantation, 36(11), 1234-1242. [More Information]
Lau, E., Giannoulatou, E., Celermajer, D., Humbert, M. (2017). Epidemiology and treatment of pulmonary arterial hypertension. Nature Reviews Cardiology, 14(10), 603-614. [More Information]
Girerd, B., Lau, E., Montani, D., Humbert, M. (2017). Genetics of pulmonary hypertension in the clinic. Current Opinion in Pulmonary Medicine, 23(5), 386-391. [More Information]
Chemla, D., Lau, E., Hervé, P., Millasseau, S., Brahimi, M., Zhu, K., Sattler, C., Garcia, G., Attal, P., Nitenberg, A. (2017). Influence of critical closing pressure on systemic vascular resistance and total arterial compliance: A clinical invasive study | Etude clinique invasive de l'influence de la pression critique de fermeture sur la resistance vasculaire systémique et la compliance arterielle totale. Archives of Cardiovascular Diseases, 110(12), 659-666. [More Information]
Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T., Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017). Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate? Internal Medicine Journal, 47(10), 1124-1128. [More Information]
Montani, D., Lau, E., Descatha, A., Humbert, M. (2017). Pulmonary veno-occlusive disease as an occupational lung disease. The Lancet Respiratory Medicine, 5(5), e19-e19. [More Information]
Seccombe, L., Chow, V., Zhao, W., Lau, E., Rogers, P., Ng, A., Veitch, E., Peters, M., Kritharides, L. (2017). Right heart function during simulated altitude in patients with pulmonary arterial hypertension. Open Heart, 4(1), 1-8. [More Information]
Lau, E., Celermajer, D., Keogh, A., Thakkar, V. (2017). Screening of Pulmonary Arterial Hypertension. Seminars in Respiratory and Critical Care Medicine, 38(5), 596-605. [More Information]
Othman, J., Robbins, E., Lau, E., Mak, C., Bryant, C. (2017). Tattoo Pigment-Induced Granulomatous Lymphadenopathy Mimicking Lymphoma. Annals of Internal Medicine, 167(11), 830-831. [More Information]
Lau, E., Roche, N., Reddel, H. (2017). Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap. Expert Review of Clinical Immunology, 13(5), 449-455. [More Information]
Thakkar, V., Lau, E. (2016). Connective tissue disease-related pulmonary arterial hypertension. Best Practice & Research: Clinical Rheumatology, 30(1), 22-38. [More Information]
Godinas, L., Lau, E., Chemla, D., Lador, F., Savale, L., Montani, D., Jais, X., Sitbon, O., Simonneau, G., Humbert, M., et al (2016). Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure. European Respiratory Journal, 48(1), 254-257. [More Information]
Lau, E., Chemla, D., Whyte, K., Kovacs, G., Olschewski, H., Herve, P. (2016). Does exercise pulmonary hypertension exist? Current Opinion in Pulmonary Medicine, 22(5), 400-407. [More Information]
Troy, L., Young, I., Lau, E., Corte, T. (2016). Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia. Respirology, 21(6), 1005-1014. [More Information]
Chia, E., Lau, E., Xuan, W., Celermajer, D., Thomas, L. (2016). Exercise testing can unmask right ventricular dysfunction in systemic sclerosis patients with normal resting pulmonary artery pressure. International Journal of Cardiology, 204, 179-186. [More Information]
Girerd, B., Montani, D., Jais, X., Eyries, M., Yaici, A., Sztrymf, B., Savale, L., Parent, F., Coulet, F., Lau, E., et al (2016). Genetic counselling in a national referral centre for pulmonary hypertension. European Respiratory Journal, 47(2), 541-552. [More Information]
Lau, E., Chemla, D., Godinas, L., Zhu, K., Sitbon, O., Savale, L., Montani, D., Jais, X., Celermajer, D., Simonneau, G., et al (2016). Loss of Vascular Distensibility During Exercise is an Early Hemodynamic Marker of Pulmonary Vascular Disease. Chest, 149(2), 353-361. [More Information]
Godinas, L., Amar, D., Montani, D., Lau, E., Jais, X., Savale, L., Jevnikar, M., Sitbon, O., Simonneau, G., Humbert, M., et al (2016). Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension. Journal Of Heart And Lung Transplantation, 35(5), 647-656. [More Information]
Lau, E., Naeije, R. (2016). Provocative testing of the pulmonary circulation: advances and unresolved issues. European Respiratory Journal, 48(1), 18-20. [More Information]
Montani, D., Lau, E., Dorfmuller, P., Girerd, B., Jais, X., Savale, L., Perros, F., Nossent, E., Garcia, G., Parent, F., et al (2016). Pulmonary veno-occlusive disease. European Respiratory Journal, 47(5), 1518-1534. [More Information]
Lau, E., Godinas, L., Sitbon, O., Montani, D., Savale, L., Jais, X., Lador, F., Gunther, S., Celermajer, D., Simonneau, G., et al (2016). Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics. European Respiratory Journal, 47(5), 1436-1444. [More Information]
Arnott, C., Boehm, C., Lau, E., Celermajer, D. (2016). Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia, 8(1), 3-7. [More Information]
Lau, E., Thakkar, V., Humbert, M., Herve, P. (2016). To stress or not to stress? Exercise pulmonary haemodynamic testing in systemic sclerosis. European Respiratory Journal, 48(6), 1549-1552. [More Information]
Lau, E., Humbert, M. (2015). A Critical Appraisal of the Updated 2014 Nice Pulmonary Hypertension Classification System. Canadian Journal of Cardiology, 31(4), 367-374. [More Information]
Fabrice, A., Benoît, R., Valérie, N., Lau, E., Sébastien, B., Frédéric, P. (2015). A simple method to assess in vivo proliferation in lung vasculature with EdU: The case of MMC-induced PVOD in rat. Analytical Cellular Pathology, 2015. [More Information]
Ranchoux, B., Günther, S., Quarck, R., Chaumais, M., Dorfmüller, P., Antigny, F., Dumas, S., Raymond, N., Lau, E., Savale, L., et al (2015). Chemotherapy-induced pulmonary hypertension: Role of alkylating agents. American Journal of Pathology, 185(2), 356-371. [More Information]
Herve, P., Lau, E., Sitbon, O., Savale, L., Montani, D., Godinas, L., Lador, F., Jais, X., Parent, F., Gunther, S., et al (2015). Criteria for diagnosis of exercise pulmonary hypertension. European Respiratory Journal, 46(3), 728-737. [More Information]
Ge, Q., Zeng, Q., Tjin, G., Lau, E., Black, J., Oliver, B., Burgess, J. (2015). Differential deposition of fibronectin by asthmatic bronchial epithelial cells. AJP: Lung Cellular and Molecular Physiology, 309(10), L1093-L1192. [More Information]
Sharma, T., Lau, E., Choudhary, P., Torzillo, P., Munoz, P., Simmons, L., Naeije, R., Celermajer, D. (2015). Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. European Respiratory Journal, 45(3), 700-708. [More Information]
Lau, E., Humbert, M., Celermajer, D. (2015). Early detection of pulmonary arterial hypertension. Nature Reviews Cardiology, 12(3), 143-155. [More Information]
Montani, D., Lau, E., Descatha, A., Jaïs, X., Savale, L., Andujar, P., Bensefa-Colas, L., Girerd, B., Zendah, I., Le Pavec, J., et al (2015). Occupational exposure to organic solvents: A risk factor for pulmonary veno-occlusive disease. European Respiratory Journal, 46(6), 1721-1731. [More Information]
Chemla, D., Millasseau, S., Lau, E., Attal, P., Nittenberg, A. (2015). P4-32: Estimation of central systolic pressure : are peripheral waveforms and transfer function necessary? Annales de Cardiologie et d'Angeiologie, 64, S34. [More Information]
Chemla, D., Lau, E., Papelier, Y., Attal, P., Herve, P. (2015). Pulmonary vascular resistance and compliance relationship in pulmonary hypertension. European Respiratory Journal, 46(4), 1178-1189. [More Information]
Harari, S., Lau, E., Tamura, Y., Cottin, V., Simonneau, G., Humbert, M. (2015). Rare (pulmonary) disease day: "feeding the breath, energy for life!". European Respiratory Journal, 45(2), 297-300. [More Information]
Gunther, S., Sztrymf, B., Savale, L., Lau, E., Montani, D., Herve, P., Lador, F., Jais, X., Parent, F., Simonneau, G., et al (2015). Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension. International Journal of Cardiology, 184(1), 763-765. [More Information]
Lau, E., Montani, D., Jais, X., Sitbon, O., Simonneau, G., Humbert, M. (2015). Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension". Circulation, 132(12), e154. [More Information]
Lau, E., Tamura, Y., McGoon, M., Sitbon, O. (2015). The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress. European Respiratory Journal, 46(4), 879-882. [More Information]
Lau, E., Celermajer, D., Naeije, R. (2015). The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension. European Respiratory Journal, 45(6), 1758-1759. [More Information]
Creuzé, N., Hoette, S., Montani, D., Günther, S., Lau, E., Ternacle, J., Savale, L., Jaïs, X., Parent, F., Girerd, B., et al (2015). Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension. Canadian Journal of Cardiology, 31(12), 1469-1476. [More Information]
Marc, H., Lau, E., Montani, D., Jais, X., Sitbon, O., Simonneau, G. (2014). Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension. Circulation, 130(24), 2189-2208. [More Information]
Lau, E., Abelson, D., Dwyer, N., Yu, Y., Ng, M., Celermajer, D. (2014). Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis. European Respiratory Journal, 43(6), 1804-1807. [More Information]
Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
Lau, E., Celermajer, D. (2014). Protecting our children from environmental tobacco smoke: one of our great healthcare challenges. European Heart Journal, 35(36), 2452-2453. [More Information]
Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. European Respiratory Journal, 41(5), 1234-1237. [More Information]
Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]
Lau, E., McCaughan, G., Torzillo, P. (2012). A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations. Internal Medicine Journal, 42(5), 600-601. [More Information]
Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PloS One, 7(3), 1-6. [More Information]
Lau, E., Corte, T. (2012). Pulmonary hypertension in 2012: contemporary issues in diagnosis and management. Panminerva Medica, 54(1), 11-28. [More Information]
Lau, E., Cooper, W., Bye, P., Yan, K. (2011). Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale. Respirology, 16(1), 180-181. [More Information]
Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
Bye, P., Lau, E., Elkins, M. (2011). Pharmacological airway clearance strategies in bronchiectasis. European Respiratory Monograph, , 239-247.
Lau, E., Barnes, D., Moriarty, C., Ogle, R., Dentice, R., Civitico, J., Avedello, A., Torzillo, P., Bye, P. (2011). Pregnancy outcomes in the current era of cystic fibrosis care: A 15-year experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51(3), 220-224. [More Information]
Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]
Lau, E., McCaughan, G., Torzillo, P. (2010). Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism. Liver Transplantation, 16(7), 870-873. [More Information]
Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]
Lau, E., Yozghatlian, V., Kosky, C., Moriarty, C., Dentice, R., Waugh, R., Torzillo, P., Bye, P. (2009). Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis. Chest, 136(1), 277-281. [More Information]

show 103 more

By Year

Expand all

2024

Lau, E., Bloomfield, P., Kotlyar, E., Makanji, Y., Yu, D., Tan, J., Casorso, J., Kouhkamari, M., Lim, S., Wu, D. (2024). Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study. Journal of Medical Economics, 27(1), 596-604. [More Information]
Kearney, K., Keogh, A., Kotlyar, E., Lavender, M., McWilliams, T., Williams, T., Whitford, H., Weintraub, R., Wrobel, J., Ellender, C., Lau, E., Celermajer, D., Cordina, R., et al (2024). Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy. Chest. [More Information]
Hungerford, S., Kearney, K., Li, C., Song, N., Everett, K., Gulati, G., Olsen, N., Lau, E., Jabbour, A., Bart, N., et al (2024). Pulsatile Vascular Afterload Measurement Improves Prediction of Right-Sided Heart Dysfunction in Undifferentiated and Left-Sided Pulmonary Hypertension. Journal of the American Heart Association, 13(23). [More Information]
Chao, H., Yee, B., Hsu, C., Chen, H., Lau, E. (2024). Sleep-related disorders in patients with precapillary pulmonary hypertension. Sleep Medicine Reviews, 77, 101972. [More Information]

show 1 more

2023

Karimi Galougahi, K., Zhang, Y., Kienzle, V., Liu, C., Quek, L., Patel, S., Lau, E., Cordina, R., Figtree, G., Celermajer, D. (2023). β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension. Physiological Reports, 11(1). [More Information]
Chandrasekara, S., Lau, E., Anderson, J., Collins, N., Cordina, R., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., Keogh, A., et al (2023). Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing. Heart, Lung, and Circulation, 32(2), 156-165. [More Information]
Hungerford, S., Kearney, K., Song, N., Kotlyar, E., Bart, N., Lau, E., Jabbour, A., Hayward, C., Muller, D., Adji, A. (2023). Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification. Physiological Reports, 11(7). [More Information]
Bell, J., Munoz, P., Raffan, F., Shah, K., Shaw, M., Taylor, N., Visser, S., Yozghatlian, V., Wong, K., Sivam, S., Dwyer, T., Cunich, M., Dentice, R., Jo, H., Lau, E., et al (2023). Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Internal Medicine Journal. [More Information]
Hungerford, S., Kearney, K., Song, N., Bart, N., Kotlyar, E., Lau, E., Jabbour, A., Hayward, C., Muller, D., Adji, A. (2023). Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension. ESC Heart Failure, 10(3), 1811-1821. [More Information]
Morland, K., Williams, P., Harikrishnan, S., Minty, E., Hobohm, L., Jose, A., Badagliacca, R., Lau, E., Jing, Z., Vanderpool, R., et al (2023). Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulmonary Circulation, 13(4), e12317. [More Information]

show 3 more

2022

Othman, F., Bailey, B., Collins, N., Lau, E., Tanous, D., Rao, K., Celermajer, D., Cordina, R. (2022). Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease. Journal of the American Heart Association, 11(15). [More Information]
Anderson, J., Lau, E. (2022). Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia. JACC: Asia, 2(5), 538-546. [More Information]
Bell, J., Sivam, S., Dentice, R., Dwyer, T., Jo, H., Lau, E., Munoz, P., Nolan, S., Taylor, N., Visser, S., Yozghatlian, V., Wong, K. (2022). Quality of home spirometry performance amongst adults with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 84-87. [More Information]

2021

Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Adelstein, S., Webster, S., Corte, T. (2021). Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration, 100(9), 853-864. [More Information]
Kearney, K., Gold, J., Corrigan, C., Dhital, K., Boshell, D., Haydock, D., McGiffin, D., Wilson, M., Collins, N., Cordina, R., Lau, E., et al (2021). Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry. Respirology, 26(12), 1171-1180. [More Information]
Cooper, W., Mahar, A., Myers, J., Grainge, C., Corte, T., Williamson, J., Vallely, M., Lai, S., Mulyadi, E., Torzillo, P., Lau, E., Troy, L., et al (2021). Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features: Further Lessons from COLDICE, a Prospective Multi-Center Study. American Journal of Respiratory and Critical Care Medicine, 203(10), 1306-1313. [More Information]
Jee, A., Parker, M., Bleasel, J., Troy, L., Lau, E., Jo, H., Teoh, A., Webster, S., Adelstein, S., Corte, T. (2021). Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine, 187, 106581. [More Information]
Tran, D., Munoz, P., Lau, E., Alison, J., Brown, M., Zheng, Y., Corkery, P., Wong, K., Lindstrom, S., Celermajer, D., Davis, G., Cordina, R. (2021). Inspiratory Muscle Training Improves Inspiratory Muscle Strength and Functional Exercise Capacity in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Pilot Randomised Controlled Study. Heart, Lung, and Circulation, 30(3), 388-395. [More Information]
Cooper, W., Mahar, A., Myers, J., Grainge, C., Corte, T., Williamson, J., Lau, E., Raghu, G., Troy, L. (2021). Letters to the Editor. Archives of Pathology & Laboratory Medicine, 145(11), 1326-1327. [More Information]
McLean, A., Webster, S., Fry, M., Lau, E., Corte, P., Torzillo, P., Troy, L., Jo, H., Geis, M., Rhodes, J., Spencer, L., Corte, T., et al (2021). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology, 26(1), 80-86. [More Information]
Kearney, K., Kotlyar, E., Lau, E. (2021). Pulmonary Vascular Disease as a Systemic and Multisystem Disease. Clinics in Chest Medicine, 42(1), 167-177. [More Information]
Humbert, M., Lau, E. (2021). Risk Stratification in PAH: Do Not Forget the Patient Perspective!. American Journal of Respiratory and Critical Care Medicine, 203(6), 675-677. [More Information]
Montani, D., Girerd, B., Jaïs, X., Laveneziana, P., Lau, E., Bouchachi, A., Hascoët, S., Günther, S., Godinas, L., Parent, F., et al (2021). Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation. European Respiratory Journal, 58(1), 2004229-1-2004229-16. [More Information]
Chemla, D., Berthelot, E., Weatherald, J., Lau, E., Savale, L., Beurnier, A., Montani, D., Sitbon, O., Attal, P., Boulate, D., et al (2021). The isobaric pulmonary arterial compliance in pulmonary hypertension. ERJ Open Research, 7(2), 941-2020. [More Information]
Kearney, K., Lau, E., Darley, D., Romfh, A., Bart, N., Kotlyar, E., Hayes, D., Khush, K., Keogh, A. (2021). Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies. Journal Of Heart And Lung Transplantation, 40(8), 841-849. [More Information]

show 9 more

2020

Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Myers, J., Lai, S., Mulyadi, E., Torzillo, P., Jo, H., Harris, B., Lau, E., et al (2020). Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. The Lancet Respiratory Medicine, 8(2), 171-181. [More Information]
Khou, V., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Lau, E., et al (2020). Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology, 25(8), 863-871. [More Information]
Lau, E., Grainge, C., Williamson, J., Corte, T., Cooper, W., Phillips, M., Torzillo, P., Vallely, M., Raghu, G., Troy, L. (2020). Methodologies of COLDICE and Cryo-PID studies: details make the difference. Annals of Translational Medicine, 8(12), 781. [More Information]
Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Keogh, A., et al (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart, Lung, and Circulation, 29(10), 1459-1468. [More Information]
Piper, A., Lau, E. (2020). Positive airway pressure in obesity hypoventilation: Getting to the heart of the matter. American Journal of Respiratory and Critical Care Medicine, 201(5), 509-511. [More Information]
Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., Lau, E., et al (2020). Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. European Respiratory Journal, 56(1), 1901654. [More Information]
Anderson, J., Lau, E., Lavender, M., Benza, R., Celermajer, D., Collins, N., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., et al (2020). Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Chest, 157(1), 162-172. [More Information]
Nanayakkara, B., Lau, E., Yee, B., Gauthier, G., Melehan, K., Celermajer, D., Cordina, R. (2020). Sleep disordered breathing in adults living with a Fontan circulation and CPAP titration protocol. International Journal of Cardiology, 317, 70-74. [More Information]

show 5 more

2019

Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Lai, S., Mulyadi, E., Torzillo, P., Lau, E., et al (2019). Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre study. BMJ Open Respiratory Research, 6(1), 1-8. [More Information]
Chemla, D., Boulate, D., Weatherald, J., Lau, E., Attal, P., Savale, L., Montani, D., Fadel, E., Mercier, O., Sitbon, O., et al (2019). Golden ratio and the proportionality between pulmonary pressure components in pulmonary arterial hypertension. Chest, 155(5), 991-998. [More Information]
Troy, L., Young, I., Lau, E., Wong, K., Yee, B., Torzillo, P., Corte, T. (2019). Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease. Respirology, 24(10), 996-1004. [More Information]
Humbert, M., Lau, E. (2019). POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes. Chest, 156(6), 1039-1042. [More Information]
Humbert, M., Lau, E. (2019). Rebuttal From Drs Humbert and Lau. Chest, 156(6), 1045-1046. [More Information]
Chemla, D., Boulate, D., Weatherald, J., Lau, E., Herve, P. (2019). Response. Chest, 156(3), 630-631. [More Information]
Gunther, S., Perros, F., Rautou, P., Girerd, B., Ghigna, M., Cazals-Hatem, D., Lau, E., Dorfmuller, P., Sitbon, O., Valla, D., et al (2019). Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease. American Journal of Pathology, 189(6), 1159-1175. [More Information]
Bailey, D., Farrow, C., Lau, E. (2019). V/Q SPECT - Normal Values for Lobar Function and Comparison With CT Volumes. Seminars in Nuclear Medicine, 49(1), 58-61. [More Information]

show 5 more

2018

Rutting, S., Xenaki, D., Lau, E., Horvat, J., Wood, L., Hansbro, P., Oliver, B. (2018). Dietary omega-6, but not omega-3 polyunsaturated or saturated fatty acids, increase inflammation in primary lung mesenchymal cells. AJP: Lung Cellular and Molecular Physiology, 314(6), L922-L935. [More Information]
Phan, K., Jo, H., Xu, J., Lau, E. (2018). Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis. Heart, Lung, and Circulation, 27(1), 89-98. [More Information]
Tran, D., Lau, E., Celermajer, D., Davis, G., Cordina, R. (2018). Pathophysiology of exercise intolerance in pulmonary arterial hypertension. Respirology, 23(2), 148-159. [More Information]
Dumas, O., Despreaux, T., Perros, F., Lau, E., Andujar, P., Humbert, M., Montani, D., Descatha, A. (2018). Respiratory effects of trichloroethylene. Respiratory Medicine, 134, 47-53. [More Information]
Strange, G., Lau, E., Giannoulatou, E., Corrigan, C., Kotlyar, E., Kermeen, F., Williams, T., Celermajer, D., Dwyer, N., Whitford, H., et al (2018). Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Heart, Lung, and Circulation, 27(11), 1368-1375. [More Information]

show 2 more

2017

Kovacs, G., Herve, P., Barbera, J., Chaouat, A., Chemla, D., Condliffe, R., Garcia, G., Grunig, E., Howard, L., Humbert, M., et al (2017). An official European Respiratory Society statement: pulmonary haemodynamics during exercise. European Respiratory Journal, 50(5), 1-18. [More Information]
Weatherald, J., Boucly, A., Lau, E., Godinas, L., Savale, L., Jais, X., Montani, D., Sitbon, O., Simonneau, G., Humbert, M., et al (2017). Are indexed values better for defining exercise pulmonary hypertension? European Respiratory Journal, 50(3), 1-4. [More Information]
Montani, D., Girerd, B., Jais, X., Levy, M., Amar, D., Savale, L., Dorfmuller, P., Seferian, A., Lau, E., Eyries, M., et al (2017). Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study. The Lancet Respiratory Medicine, 5(2), 125-134. [More Information]
Godinas, L., Sattler, C., Lau, E., Jais, X., Taniguchi, Y., Jevnikar, M., Weatherald, J., Sitbon, O., Savale, L., Montani, D., et al (2017). Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension. Journal Of Heart And Lung Transplantation, 36(11), 1234-1242. [More Information]
Lau, E., Giannoulatou, E., Celermajer, D., Humbert, M. (2017). Epidemiology and treatment of pulmonary arterial hypertension. Nature Reviews Cardiology, 14(10), 603-614. [More Information]
Girerd, B., Lau, E., Montani, D., Humbert, M. (2017). Genetics of pulmonary hypertension in the clinic. Current Opinion in Pulmonary Medicine, 23(5), 386-391. [More Information]
Chemla, D., Lau, E., Hervé, P., Millasseau, S., Brahimi, M., Zhu, K., Sattler, C., Garcia, G., Attal, P., Nitenberg, A. (2017). Influence of critical closing pressure on systemic vascular resistance and total arterial compliance: A clinical invasive study | Etude clinique invasive de l'influence de la pression critique de fermeture sur la resistance vasculaire systémique et la compliance arterielle totale. Archives of Cardiovascular Diseases, 110(12), 659-666. [More Information]
Moonen, A., Garsia, R., Youssef, P., Torzillo, P., Corte, T., Boehm, C., Cordina, R., Celermajer, D., Lau, E. (2017). Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate? Internal Medicine Journal, 47(10), 1124-1128. [More Information]
Montani, D., Lau, E., Descatha, A., Humbert, M. (2017). Pulmonary veno-occlusive disease as an occupational lung disease. The Lancet Respiratory Medicine, 5(5), e19-e19. [More Information]
Seccombe, L., Chow, V., Zhao, W., Lau, E., Rogers, P., Ng, A., Veitch, E., Peters, M., Kritharides, L. (2017). Right heart function during simulated altitude in patients with pulmonary arterial hypertension. Open Heart, 4(1), 1-8. [More Information]
Lau, E., Celermajer, D., Keogh, A., Thakkar, V. (2017). Screening of Pulmonary Arterial Hypertension. Seminars in Respiratory and Critical Care Medicine, 38(5), 596-605. [More Information]
Othman, J., Robbins, E., Lau, E., Mak, C., Bryant, C. (2017). Tattoo Pigment-Induced Granulomatous Lymphadenopathy Mimicking Lymphoma. Annals of Internal Medicine, 167(11), 830-831. [More Information]
Lau, E., Roche, N., Reddel, H. (2017). Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap. Expert Review of Clinical Immunology, 13(5), 449-455. [More Information]

show 10 more

2016

Thakkar, V., Lau, E. (2016). Connective tissue disease-related pulmonary arterial hypertension. Best Practice & Research: Clinical Rheumatology, 30(1), 22-38. [More Information]
Godinas, L., Lau, E., Chemla, D., Lador, F., Savale, L., Montani, D., Jais, X., Sitbon, O., Simonneau, G., Humbert, M., et al (2016). Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure. European Respiratory Journal, 48(1), 254-257. [More Information]
Lau, E., Chemla, D., Whyte, K., Kovacs, G., Olschewski, H., Herve, P. (2016). Does exercise pulmonary hypertension exist? Current Opinion in Pulmonary Medicine, 22(5), 400-407. [More Information]
Troy, L., Young, I., Lau, E., Corte, T. (2016). Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia. Respirology, 21(6), 1005-1014. [More Information]
Chia, E., Lau, E., Xuan, W., Celermajer, D., Thomas, L. (2016). Exercise testing can unmask right ventricular dysfunction in systemic sclerosis patients with normal resting pulmonary artery pressure. International Journal of Cardiology, 204, 179-186. [More Information]
Girerd, B., Montani, D., Jais, X., Eyries, M., Yaici, A., Sztrymf, B., Savale, L., Parent, F., Coulet, F., Lau, E., et al (2016). Genetic counselling in a national referral centre for pulmonary hypertension. European Respiratory Journal, 47(2), 541-552. [More Information]
Lau, E., Chemla, D., Godinas, L., Zhu, K., Sitbon, O., Savale, L., Montani, D., Jais, X., Celermajer, D., Simonneau, G., et al (2016). Loss of Vascular Distensibility During Exercise is an Early Hemodynamic Marker of Pulmonary Vascular Disease. Chest, 149(2), 353-361. [More Information]
Godinas, L., Amar, D., Montani, D., Lau, E., Jais, X., Savale, L., Jevnikar, M., Sitbon, O., Simonneau, G., Humbert, M., et al (2016). Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension. Journal Of Heart And Lung Transplantation, 35(5), 647-656. [More Information]
Lau, E., Naeije, R. (2016). Provocative testing of the pulmonary circulation: advances and unresolved issues. European Respiratory Journal, 48(1), 18-20. [More Information]
Montani, D., Lau, E., Dorfmuller, P., Girerd, B., Jais, X., Savale, L., Perros, F., Nossent, E., Garcia, G., Parent, F., et al (2016). Pulmonary veno-occlusive disease. European Respiratory Journal, 47(5), 1518-1534. [More Information]
Lau, E., Godinas, L., Sitbon, O., Montani, D., Savale, L., Jais, X., Lador, F., Gunther, S., Celermajer, D., Simonneau, G., et al (2016). Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics. European Respiratory Journal, 47(5), 1436-1444. [More Information]
Arnott, C., Boehm, C., Lau, E., Celermajer, D. (2016). Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia, 8(1), 3-7. [More Information]
Lau, E., Thakkar, V., Humbert, M., Herve, P. (2016). To stress or not to stress? Exercise pulmonary haemodynamic testing in systemic sclerosis. European Respiratory Journal, 48(6), 1549-1552. [More Information]

show 10 more

2015

Lau, E., Humbert, M. (2015). A Critical Appraisal of the Updated 2014 Nice Pulmonary Hypertension Classification System. Canadian Journal of Cardiology, 31(4), 367-374. [More Information]
Fabrice, A., Benoît, R., Valérie, N., Lau, E., Sébastien, B., Frédéric, P. (2015). A simple method to assess in vivo proliferation in lung vasculature with EdU: The case of MMC-induced PVOD in rat. Analytical Cellular Pathology, 2015. [More Information]
Ranchoux, B., Günther, S., Quarck, R., Chaumais, M., Dorfmüller, P., Antigny, F., Dumas, S., Raymond, N., Lau, E., Savale, L., et al (2015). Chemotherapy-induced pulmonary hypertension: Role of alkylating agents. American Journal of Pathology, 185(2), 356-371. [More Information]
Herve, P., Lau, E., Sitbon, O., Savale, L., Montani, D., Godinas, L., Lador, F., Jais, X., Parent, F., Gunther, S., et al (2015). Criteria for diagnosis of exercise pulmonary hypertension. European Respiratory Journal, 46(3), 728-737. [More Information]
Ge, Q., Zeng, Q., Tjin, G., Lau, E., Black, J., Oliver, B., Burgess, J. (2015). Differential deposition of fibronectin by asthmatic bronchial epithelial cells. AJP: Lung Cellular and Molecular Physiology, 309(10), L1093-L1192. [More Information]
Sharma, T., Lau, E., Choudhary, P., Torzillo, P., Munoz, P., Simmons, L., Naeije, R., Celermajer, D. (2015). Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. European Respiratory Journal, 45(3), 700-708. [More Information]
Lau, E., Humbert, M., Celermajer, D. (2015). Early detection of pulmonary arterial hypertension. Nature Reviews Cardiology, 12(3), 143-155. [More Information]
Montani, D., Lau, E., Descatha, A., Jaïs, X., Savale, L., Andujar, P., Bensefa-Colas, L., Girerd, B., Zendah, I., Le Pavec, J., et al (2015). Occupational exposure to organic solvents: A risk factor for pulmonary veno-occlusive disease. European Respiratory Journal, 46(6), 1721-1731. [More Information]
Chemla, D., Millasseau, S., Lau, E., Attal, P., Nittenberg, A. (2015). P4-32: Estimation of central systolic pressure : are peripheral waveforms and transfer function necessary? Annales de Cardiologie et d'Angeiologie, 64, S34. [More Information]
Chemla, D., Lau, E., Papelier, Y., Attal, P., Herve, P. (2015). Pulmonary vascular resistance and compliance relationship in pulmonary hypertension. European Respiratory Journal, 46(4), 1178-1189. [More Information]
Harari, S., Lau, E., Tamura, Y., Cottin, V., Simonneau, G., Humbert, M. (2015). Rare (pulmonary) disease day: "feeding the breath, energy for life!". European Respiratory Journal, 45(2), 297-300. [More Information]
Gunther, S., Sztrymf, B., Savale, L., Lau, E., Montani, D., Herve, P., Lador, F., Jais, X., Parent, F., Simonneau, G., et al (2015). Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension. International Journal of Cardiology, 184(1), 763-765. [More Information]
Lau, E., Montani, D., Jais, X., Sitbon, O., Simonneau, G., Humbert, M. (2015). Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension". Circulation, 132(12), e154. [More Information]
Lau, E., Tamura, Y., McGoon, M., Sitbon, O. (2015). The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress. European Respiratory Journal, 46(4), 879-882. [More Information]
Lau, E., Celermajer, D., Naeije, R. (2015). The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension. European Respiratory Journal, 45(6), 1758-1759. [More Information]
Creuzé, N., Hoette, S., Montani, D., Günther, S., Lau, E., Ternacle, J., Savale, L., Jaïs, X., Parent, F., Girerd, B., et al (2015). Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension. Canadian Journal of Cardiology, 31(12), 1469-1476. [More Information]

show 13 more

2014

Marc, H., Lau, E., Montani, D., Jais, X., Sitbon, O., Simonneau, G. (2014). Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension. Circulation, 130(24), 2189-2208. [More Information]
Lau, E., Abelson, D., Dwyer, N., Yu, Y., Ng, M., Celermajer, D. (2014). Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis. European Respiratory Journal, 43(6), 1804-1807. [More Information]
Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
Lau, E., Celermajer, D. (2014). Protecting our children from environmental tobacco smoke: one of our great healthcare challenges. European Heart Journal, 35(36), 2452-2453. [More Information]
Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]

show 2 more

2013

Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. European Respiratory Journal, 41(5), 1234-1237. [More Information]
Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]

2012

Lau, E., McCaughan, G., Torzillo, P. (2012). A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations. Internal Medicine Journal, 42(5), 600-601. [More Information]
Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PloS One, 7(3), 1-6. [More Information]
Lau, E., Corte, T. (2012). Pulmonary hypertension in 2012: contemporary issues in diagnosis and management. Panminerva Medica, 54(1), 11-28. [More Information]

2011

Lau, E., Cooper, W., Bye, P., Yan, K. (2011). Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale. Respirology, 16(1), 180-181. [More Information]
Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
Bye, P., Lau, E., Elkins, M. (2011). Pharmacological airway clearance strategies in bronchiectasis. European Respiratory Monograph, , 239-247.
Lau, E., Barnes, D., Moriarty, C., Ogle, R., Dentice, R., Civitico, J., Avedello, A., Torzillo, P., Bye, P. (2011). Pregnancy outcomes in the current era of cystic fibrosis care: A 15-year experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51(3), 220-224. [More Information]
Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]

show 2 more

2010

Lau, E., McCaughan, G., Torzillo, P. (2010). Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism. Liver Transplantation, 16(7), 870-873. [More Information]
Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]

2009

Lau, E., Yozghatlian, V., Kosky, C., Moriarty, C., Dentice, R., Waugh, R., Torzillo, P., Bye, P. (2009). Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis. Chest, 136(1), 277-281. [More Information]

Selected Grants

2015

Crybiopsy versus Surgical Lung Biopsy for Diagnosis of Interstitial Lung Diseases, Lau E, University of Sydney/Kickstart Grants Program

2014

Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension Detected by an Artificial Nose: A Proof-of-concept Validation Study , Lau E, Office of Global Engagement/Joint Funding Scheme with Inserm (France)

2013

Signature olfactive de lhypertension arterielle pulmonaire detectee dans les exhalats pulmonaires par un nez artificiel : de la preuve de concept a la validation , Lau E, Fondation du Souffle/Postdocoral Fellowship

Page not found

Professor Edmund Lau

Publications

By Type

By Year

Selected Grants

2015

2014

2013